|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/085 | (2006.01) |
| A61K 9/48 | (2006.01) | ||
| A61K 9/08 | (2006.01) | ||
| A61K 9/10 | (2006.01) |
| (11) | Number of the document | 2275098 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10179959.1 |
| Date of filing the European patent application | 2005-03-02 | |
| (97) | Date of publication of the European application | 2011-01-19 |
| (45) | Date of publication and mention of the grant of the patent | 2012-07-25 |
| (46) | Date of publication of the claims translation | 2012-11-26 |
| (30) | Number | Date | Country code |
| 567525 P | 2004-05-04 | US |
| (72) |
Lehtola, Veli-Matti, FI
Anttila, Markku, FI
|
| (73) |
Hormos Medical Ltd.,
Itäinen Pitkäkatu 4 B, 20520 Turku,
FI
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Ospemifeno naujos peroralinės formos |
| Novel oral formulations of ospemifene |
| Payment date | Validity (years) | Amount | |
| 2021-02-18 | 17 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2022-03-02 |